Goldman Sachs Group Inc Gossamer Bio, Inc. Call Options Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GOSS
# of Institutions
108Shares Held
167MCall Options Held
430KPut Options Held
519K-
Nea Management Company, LLC Timonium, MD18.1MShares$17.4 Million1.37% of portfolio
-
Siren, L.L.C. New York, NY13.3MShares$12.8 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$11.3 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$8.82 Million2.2% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$7.73 Million4.79% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $90.2M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...